Effectiveness of liposomal and ferrous iron in the treatment of iron deficiency

Comparison of the effectiveness of liposomal and ferrous iron in the treatment of iron deficiency in infants and children

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151020024625N17

Enrollment

Registered

2023-04-15

Start date

2023-05-05

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Iron deficiency. Condition 2: Iron deficiency anemia. Iron deficiency Other iron deficiency anemias

Interventions

Intervention 1: Intervention group: The liposomal iron, equivalent to 6 mg/kg/day of elemental iron is prescribed with a maximum dose of 200 mg/day. Intervention 2: Control group: The ferrous iron equ

Eligibility

Sex/Gender

All

Age

6 Months to 2 Years

Inclusion criteria

Inclusion criteria: Patients with iron deficiency and iron deficiency anemia

Exclusion criteria

Exclusion criteria: A history for use of iron supplements Hemoglobinopathy Severe anemia or anemia due to other causes Asthma Malignancy Active infection Renal dysfunction

Design outcomes

Primary

Measure	Time frame
Serum Iron. Timepoint: Before and 4 and 12 weeks after intervention. Method of measurement: Biochemical test.;Ferritin. Timepoint: Before and 4 and 12 weeks after intervention. Method of measurement: Biochemical test.;Total Iron-Binding Capacity. Timepoint: Before and 4 and 12 weeks after intervention. Method of measurement: Biochemical test.;Hemoglubin. Timepoint: Before and 4 and 12 weeks after intervention. Method of measurement: Hematological test.;Hematocrit. Timepoint: Before and 4 and 12 weeks after intervention. Method of measurement: Hematological test.	—

Measure

Time frame

Serum Iron. Timepoint: Before and 4 and 12 weeks after intervention. Method of measurement: Biochemical test.;Ferritin. Timepoint: Before and 4 and 12 weeks after intervention. Method of measurement: Biochemical test.;Total Iron-Binding Capacity. Timepoint: Before and 4 and 12 weeks after intervention. Method of measurement: Biochemical test.;Hemoglubin. Timepoint: Before and 4 and 12 weeks after intervention. Method of measurement: Hematological test.;Hematocrit. Timepoint: Before and 4 and 12 weeks after intervention. Method of measurement: Hematological test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Nomani

Semnan University of Medical Sciences

maryam.nomani@gmail.com+98 23 3346 0055

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026